Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Arbutus Biopharma Corporation
Business Segments
Products & Services
License receivable from Genevant
License receivable from Genevant
Arbutus Biopharma Corporation
·
Products & Services
·
1 segment
·
Rolls up to
Accounts Receivable
Breakdown
Segments
Revenue from collaborations and licenses
View metric
Quarterly
Annual
TTM
Segment
Q1 '26
Revenue from collaborations and licenses
$178.7M
Total
$178.74M